KRAS Diagnostic Test That Assists With Personalized Treatment Of Colorectal Cancer Receives CE Mark
7/22/2011
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the cobas KRAS Mutation Test is now commercially available in Europe for use in colorectal cancer. The cobas KRAS Mutation Test identifies mutations in the KRAS gene of colorectal cancer tissue that are predictive of individual response to therapy with anti-epidermal growth factor receptor (EGFR) antibody therapies...
Mammography screening should start when a woman is 40 years old, and should be offered yearly from that age, says the American College of Obstetricians and Gynecologists (ACOG). The new guidelines are in response to the USA's high breast cancer rate, ACOG added that the death rate can be significantly reduced if breast cancer is detected early...
Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, found that metabolic syndrome significantly increases risk of developing these primary liver cancers...
AstraZeneca Brilinta Blood Thinner FDA Approved; Boxed Warning
7/21/2011
Sometimes blood has a hard time making it to your heart to be cleaned and sent back out to the body in order to do its necessary functions. Now, in a highly anticipated approval, the U.S...
Researchers Exploring Keys To Melanoma Progression
7/21/2011
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors...
Researchers Discover Gene Required To Maintain Male Sex Throughout Life
7/21/2011
University of Minnesota Medical School and College of Biological Sciences researchers have made a key discovery showing that male sex must be maintained throughout life. The research team, led by Drs...
New Breast Cancer Drug: Promising Results Of PI3K Inhibitor Study Discussed At ASCO Annual Meeting
7/21/2011
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO)...
Questioning The Benefit Of PET In Malignant Melanoma
7/21/2011
The relevance of positron emission tomography (PET) alone or in combination with computed tomography (CT) in patients with malignant melanoma cannot be currently assessed due to a lack of meaningful studies. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 20 July 2011...
Schizophrenia Patients May Benefit From Cancer Drugs
7/21/2011
Researchers have revealed the molecular pathway that is affected during the onset of schizophrenia and successfully alleviated symptoms of the illness in mice, using a cancer drug currently in advanced clinical trials. The research, published online in the journal Brain, is from a group led by Professor Peter Giese at King's College London, and offers new avenues for drug discovery...
Taller People Have Higher Cancer Risk
7/21/2011
Taller people have a higher risk of developing a large range of cancers, said scientists from a Cancer UK-funded study published online in The Lancet on Thursday...